% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schttker:127475,
author = {B. Schöttker$^*$ and Y. Zhang$^*$ and J. Heiss$^*$ and K.
Butterbach$^*$ and E. H. J. M. Jansen and M.
Bewerunge-Hudler$^*$ and K.-U. Saum$^*$ and B. Holleczek and
H. Brenner$^*$},
title = {{D}iscovery of a novel epigenetic cancer marker related to
the oxidative status of human blood.},
journal = {Genes, chromosomes $\&$ cancer},
volume = {54},
number = {9},
issn = {1045-2257},
address = {New York, NY},
publisher = {Wiley-Liss},
reportid = {DKFZ-2017-03498},
pages = {583 - 594},
year = {2015},
abstract = {Long-lasting oxidative stress exposure may lead to
relatively stable epigenetic modifications of the DNA in
order to activate anti-oxidative defence mechanisms.
Oxidative stress related DNA methylation may therefore be
associated (causally or as a by-product) with cancer. We
measured derivatives of reactive oxygen metabolites (D-ROM),
total thiol levels (TTL) and DNA methylation with the
Illumina Infinium 450K BeadChip in three samples of German
individuals aged ≥50 years: n = 1,000 ESTHER study
baseline participants (DNA methylation only), n = 99
ESTHER eight-year follow-up participants and n = 142
participants of the BLITZ study. The correlation coefficient
of methylation at cg10342304 and D-ROM in the ESTHER 8-year
follow-up sample (r = -0.427; P = 1 × 10(-5)) was
replicated with a P-value indicating statistical
significance after correction for multiple testing in the
BLITZ sample (r = -0.192; P = 0.022). The
association was robust to adjusting for potential
confounders. In the ESTHER baseline sample, the hazard ratio
for cancer development in 11 years of follow-up comparing
bottom and top quartile of DNA methylation at cg10342304 was
1.86 $(95\%-confidence-interval$ 1.01-3.43). In summary,
this first epigenome-wide screening and replication study
with oxidative status markers observed a negative
correlation of D-ROM levels and DNA methylation at
cg10342304 in two independent cohorts. This CpG site is
located in the body region of the nucleoredoxin gene. The
nucleoredoxin protein is a redox-dependent inhibitor of the
Wnt/ß-catenin signaling pathway, a well-characterized
cancer pathway. If the observed CpG-cancer association can
be successfully replicated by other studies, this epigenetic
marker could be an interesting biomarker of cancer risk.},
keywords = {Biomarkers, Tumor (NLM Chemicals) / Reactive Oxygen Species
(NLM Chemicals)},
cin = {C070 / W110 / G110},
ddc = {570},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)W110-20160331 /
I:(DE-He78)G110-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:26173806},
doi = {10.1002/gcc.22271},
url = {https://inrepo02.dkfz.de/record/127475},
}